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Open access under CC BY-NThe proto-oncogene Src is an important protein tyrosine kinase involved in signaling pathways that con-
trol cell adhesion, growth, migration and survival. Here, we investigated the involvement of Src family
kinases (SFKs) in human intestinal cell differentiation. We ﬁrst observed that Src activity peaked in early
stages of Caco-2/15 cell differentiation. Inhibition of SFKs with PP2, a selective SFK inhibitor, accelerated
the overall differentiation program. Interestingly, all polarization and terminal differentiation markers
tested, including sucrase-isomaltase, lactase-phlorizin hydrolase and E and Li-cadherins were found to
be signiﬁcantly up-regulated after only 3 days of treatment in the newly differentiating cells. Further
investigation of the effects of PP2 revealed a signiﬁcant up-regulation of the two main intestinal epithe-
lial cell-speciﬁc transcription factors Cdx2 and HNF1a and a reduction of polycomb PRC2-related epige-
netic repressing activity as measured by a decrease in H3K27me3, two events closely related to the
control of cell terminal differentiation in the intestine. Taken together, these data suggest that SFKs play
a key role in the control of intestinal epithelial cell terminal differentiation.
 2013 Elsevier Inc. Open access under CC BY-NC-ND license. 1. Introduction
Src family kinases (SFKs) are membrane-associated non-recep-
tor protein tyrosine kinases that play pivotal roles in regulating
various cellular processes including proliferation, adhesion, migra-
tion and survival [1]. Currently eight SFK members have been iden-
tiﬁed in mammals, namely Src, Fyn, Yes, Lyn, Lck, Hck, Fgr and Blk.
Among these, Src, Fyn and Yes are ubiquitously expressed, whereas
the others are expressed mainly in the immune system [2]. SFKs
are regulated by growth factors, cytokines, cell adhesion and anti-
gen receptor activation [1,3]. Src is generally maintained in an
inactive conformation by phosphorylation at 527Tyr. Activation re-
quires the dephosphorylation of this residue by phosphatases
which leads to intramolecular autophosphorylation at 416Tyr, pro-
moting kinase activity [4]. Src signaling has been shown to play an
important role in the regulation of enterocytic anoikis [5], migra-
tion and the oxidative stress response in intestinal epithelial cells
[6]. In colon cancer, Src has been associated with unregulated pro-
liferation and tumor progression [6,7]. Src functions are also asso-
ciated with the development of metastasis. Indeed, Src is a critical
regulator of migration and Src/ cells are deﬁcient in this processatomie et biologie cellulaire,
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C-ND license. [8]. Trevino et al. have reported that the inhibition of Src expres-
sion and activity inhibits tumor progression and metastasis of hu-
man pancreatic adenocarcinoma cells in an orthotopic nude mouse
model [9]. Src kinase was also shown to be essential for osteoclast
activation and osteoblast inhibition [10]. Recent studies have re-
ported that Src kinase plays a positive role in osteoclast differenti-
ation [11]. SFK members have also been implicated in the
differentiation of other cell types such as T cells [12], myoblasts
[13] and chondrocytes [14].
PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-
d]pyrimidine) has been identiﬁed as a potent and selective inhibi-
tor of the Src family of protein tyrosine kinases. It was originally
used as a treatment for patients with chronic myeloid leukemia
[15]. Recent studies have shown that PP2 efﬁciently inhibits the
proliferation and growth of cervical cancer cell lines [16] and it
has been reported that PP2 stimulates hormonal differentiation
of human trophoblast cells [17,18]. Furthermore, PP2 treatment
has been shown to strongly promote differentiation of primary
mouse osteoblasts isolated from mouse calvaria [19].
The epithelium of the small intestine is characterized by rapid
and constant renewal. This process involves highly hierarchized
proliferation and differentiation processes all occurring in the crypt
in order to generate the functional cells that will migrate onto the
villus [20–22]. The stem, transient amplifying and terminal differ-
entiating cells are located in the lower, middle and upper thirds of
the glands, respectively. Cell migration from the ‘‘stem cell zone’’
to the ‘‘transit amplifying zone’’ triggers the irreversible process
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several times in this compartment before undergoing terminal dif-
ferentiation in the upper gland and the mechanisms responsible
for the transient repression of absorptive cell differentiation in
the transit amplifying zone remain incompletely understood. The
Caco-2/15 cell line has proven to be an invaluable model for study-
ing absorptive cell differentiation. These cells are unique in that
upon reaching conﬂuence they spontaneously initiate a differenti-
ation program that is complete by 20–30 days post-conﬂuence
where cells are non-proliferative and display a highly polarized
morphology as well as the expression of speciﬁc biochemical
markers that are comparable to those of the enterocytes of the vil-
lus [23–26]. This model has been one of the most used human
intestinal cell models [27]. We recently used Caco-2/15 cells to
shown that epigenetic modulation via the polycomb PRC2 com-
plex, which catalyzes the trimethylation of lysine 27 in histone 3
(H3K27me3) to silent gene expression, can participate in the
repression of enterocytic terminal differentiation in the transit
amplifying cell population [28].
In the present study, we evaluated the role of Src kinase on
enterocyte differentiation by treating early differentiating Caco-
2/15 cells with the SFK inhibitor PP2. The impact of SFK inhibition
on the ﬁrst steps of differentiation was evaluated on both cell
polarity and terminal differentiation markers.2. Materials and methods
2.1. Cell culture
The Caco-2/15 cell line, provided by Dr. Quaroni (Cornell Uni-
versity, Ithaca, NY), has been characterized elsewhere [23,25,27].
2.2. Cell signaling inhibitor treatments
Caco-2/15 cells were grown as described [23,25,27]. At day 0
(conﬂuence) 20 lM PP2, a speciﬁc Src signaling pathway inhibitor,
was added to the culture medium. Controls consisted of DMSO
only. The medium was renewed daily for 72 h. Total RNA and pro-
tein were extracted from the cell monolayer for each condition
tested at 3 days post conﬂuence.
2.3. Antibodies
Mouse primary antibodies used in this study were: actin (WB:
1/75,000) (Santa Cruz Biotechnology, Santa Cruz, CA), villin (WB:
1/3000) (BD Biosciences Pharmingen, Mississauga, ON) and the
monoclonal antibody against sucrase-isomaltase (HSI-14), pro-
duced and characterized as previously described (WB: 1/10, IF: 1/
100) [26]. Rabbit primary antibodies used in this study were: the
anti-phosphorylated form of Src (WB: 1/1000) (Y416, Cell Signaling
Technology, Beverly, MA), total Src (WB: 1/1000) (Cell Signaling
Technology), E-cadherin (WB: 1/20,000, IF: 1/500) (BD Biosciences
Pharmingen) and ZO-1 (IF: 1/1000) (Zymed, Burlington, ON). Sec-
ondary antibodies used were AlexaFluor 488 goat anti-mouse
and goat anti-rabbit (Invitrogen, Burlington, ON).
2.4. Western blot
Western blots were performed on SDS–PAGE gels under dena-
turing conditions as previously described [28]. Primary antibodies
were incubated overnight at room temperature or 4 C and de-
tected using horseradish peroxidase-conjugated secondary anti-
bodies (anti-mouse, anti-rabbit, GE Healthcare-Amersham
Bioscience, Baie d’Urfe, QC) and developed using the Immobilon
Western kit (Millipore, Billerica, MA).2.5. Quantitative RT-PCR
RNA extraction, quality veriﬁcation, reverse transcription and
cDNA ampliﬁcation by real-time PCR were performed as previously
described using an Mx3000P (Stratagene, La Jolla, CA) [29,30].
Assessments of gene expression were established according to
the Pfafﬂ mathematical model using RPLPO for normalization
[31]. Human sucrase-isomaltase (SI), lactase-phlorizin hydrolase
(LCT), aminopeptidase-N (ANPEP), dipeptidylpeptidase IV (DPP4),
Cdx2 (CDX2), HNF1a (HNF1A), E-cadherin (CDH1), Li-cadherin
(CDH17), cingulin (CGN), zonula occludens 2 (TJP2) and RPLP0
were evaluated as previously described [28–32]. Primers used to
detect human apolipoprotein A1 (APOA1) were forward 50-TGGAT
GTGCTCAAAGACAGC-30 and reverse 50-AGGCCCTCTGTCTCCTTTTC-
30, for Src (SRC), forward 50-GCTGACTGAGCTCACCACAA-30 and
reverse 50-CGGTGGACGTGAAGTAGTCC-30, for Fyn (FYN), forward
50-ACGGGAGGTTCACAATCAAG-30 and reverse 50-AGGGTCCTTTTT
CCAGCAGT-30, for Lyn (LYN), forward 50-TGATGTGTGGTCCTTTG-
GAA-30 and reverse 50-CTGCCTTTTCTTTCCAGCAC-30 and for Yes
(YES), forward 50-ATGCCAGAAGCTTTCCTTCA-30 and reverse 50-
CAGCAATCTGAGCAGCCATA-30.
2.6. Indirect immunoﬂuorescence
Cells were seeded onto glass cover slips and processed as previ-
ously reported [25,33]. Both primary and secondary antibodies
were diluted in 10% Blotto-PBS. Samples were viewed with a
DMRXA microscope (Leica, Concord, ON) equipped for epiﬂuores-
cence and digital imaging (RTE/CCD Y/Hz-1300 cooled camera).
Images were acquired using MetaMorph software (Molecular De-
vices, Sunnyvale, CA) with 20 and 40 objectives.
2.7. Data presentation and statistical analyses
All experiments were performed at least three times. Student’s
unpaired t-test and ANOVA using Bonferroni’s Multiple Compari-
son Test used to analyze the results and data were considered to
be signiﬁcantly relevant at p < 0.05 and are presented respectively
as mean ± SEM. Statistical calculations were performed using
Prism 3.0 software (GraphPad Software, San Diego, CA).
3. Results
3.1. Src kinase is activated during human intestinal epithelial cell
differentiation
The Caco-2/15 cell line has been widely exploited for its unique
ability to spontaneously undertake a differentiation program upon
reaching conﬂuence which is reﬂected by robust expression of spe-
ciﬁc biomarkers [23,25] such as SI, that increases with conﬂuence.
The analysis of Src mRNA expression in Caco-2/15 cells showed
signiﬁcant increase between 0 and 30 days of post-conﬂuence
(PC), which correlated with a rise in SI levels (Fig. 1A). The activa-
tion status of Src evaluated by measuring the level of Tyr 416 phos-
phorylation (pSrcY416) showed a signiﬁcant increase upon attaining
conﬂuence and peaked at 3 days PC (Fig. 1B). Peak levels of Src
activity occurring between 0 and 3 days coincided with the begin-
ning of SI accumulation (Fig. 1B, right panel). These results suggest
that SFKs could be involved with early events of intestinal epithe-
lial cell differentiation.
3.2. Inhibition of SFKs accelerates the enterocytic differentiation
program
To further investigate the potential role of SFKs in intestinal epi-
thelial cell differentiation, we evaluated the impact of its inhibition
Fig. 1. Src kinase is activated during Caco-2/15 human intestinal epithelial cell differentiation. Whole cell protein and total RNA were isolated from Caco-2/15 cells at
different times of conﬂuence. (A) The mRNA expressions of Src (bars) and SI (curve) were determined by qPCR. (B) Protein extracts were analyzed by Western blot for
detection of SI, phosphorylated Src on tyrosine 416 (pSrcY416) and total Src as well as actin. Bar graph shows pSrcY416 normalized to total Src and the curve shows SI expression
relative to actin. (n = 3, ⁄⁄p < 0.01 and ⁄⁄⁄p < 0.001 versus SC Ctrl). SC: sub-conﬂuence.
Fig. 2. Effect of PP2 on Src phosphorylation and gene expression in Caco-2/15 cells. Newly conﬂuent cells were treated for 3 days with PP2 or control (DMSO only; Ctrl) in
complete culture medium. (A) Cell lysates were separated by SDS–PAGE, transferred to membranes and immunoblotted for pSrcY416 detection. After stripping, membranes
were reprobed with anti-Src and actin. Histogram illustrating the ratio of pSrcY416 on total Src. (B–D) qPCR analysis of intestinal cell markers. (B) SI. (C) Other terminal
differentiation markers. (D) Polarization markers. (n = 3, ⁄⁄p < 0.01 and ⁄⁄⁄p < 0.001 versus Ctrl).
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the Src inhibitor PP2 at 20 uM [5] for 3 days beginning at conﬂu-
ence. Src activity was found to be signiﬁcantly decreased as evalu-
ated by measuring the levels of pSrcY416 as an indicator of Src
kinase activity (Fig. 2A). However, surprisingly, we observed asharp increase (6) in SI transcript levels (Fig. 2B) suggesting that
Src and/or other SFKs act as a repressor of the early steps of intes-
tinal cell differentiation. Quantitative PCR of mRNA of SFKs con-
ﬁrmed that Caco-2 cells express signiﬁcant levels of various SFKs
namely Src, Fyn, Lyn and Yes (not shown). PP2 treatment caused
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(0.49 ± 0.01, mean ± SEM) and Fyn (0.31 ± 0.06).
To further investigate the effect of SFK inhibition on intestinal
cell differentiation, transcript levels of other well-characterized
intestinal cell terminal differentiation markers were analyzed by
qPCR. Interestingly, PP2 treatment during the ﬁrst 3 days of post-
conﬂuent culture induced signiﬁcant increases of all tested mark-
ers (Fig. 2C) suggesting that the effect is general and affects the en-
tire intestinal terminal differentiation program. Previous studies
had pointed towards differentiation and polarization being uncou-
pled events in newly differentiating Caco-2/15 cells [25,33].
Expression of a number of epithelial polarity markers, such as E-
cadherin, Li-cadherin, villin, cingulin and ZO-2, was therefore
investigated. PP2 treatment induced signiﬁcant up-regulation of
all tested markers at the transcript level (Fig. 2D). To determine
whether the observed increases in mRNA translated into increased
protein levels, we monitored protein expression in PP2 treated and
control cell cultures by Western blot analyses for SI and E-cad-
herin. Both markers showed signiﬁcantly increased expression at
3 days PC in PP2 treated cultures (Fig. 3A). Indirect immunoﬂuores-
cence for SI and E-cadherin conﬁrmed increased expression levels
and extended these results by showing that sucrase-isomaltaseFig. 3. Effect of PP2 on differentiation and polarity markers at the protein level.
Newly conﬂuent cells were treated for 3 days with PP2 or control (DMSO only; Ctrl)
in complete culture medium. (A) Cell lysates were prepared and analysed by
immunoblot for detection of SI and E-cadherin. Bar graphs show the amounts of
both proteins relative to actin. (n = 3, ⁄⁄p < 0.01 and ⁄⁄⁄p < 0.001 versus Ctrl). (B)
Caco-2/15 cells were cultured on sterile chamber slides until conﬂuence then
treated with or without PP2 as above. Cells were then immunostained for E-
cadherin and SI then processed for immunoﬂuorescence and picture acquisition.
Exposition times were similar.was efﬁciently and correctly inserted into the apical membrane
while E-cadherin was massively targeted to the lateral membranes
(Fig. 3B).
3.3. SFKs regulate expression of enterocyte-speciﬁc transcription
factors
The ubiquitous effect of PP2 treatment on both cell polarization
and terminal differentiation suggested that SFKs may act on a fun-
damental mechanism of enterocytic maturation. Recent work from
our laboratory has shown that the transcription factors Cdx2,
HNF1a and GATA4 cooperate in the initiation of the enterocytic
differentiation program [30]. Since GATA4 is not expressed in
Caco-2 cells [32], the inﬂuence of PP2 on the expression of Cdx2
and HNF1a was investigated. Interestingly, inhibition of SFK activ-
ity by PP2 treatment in 3 day PC cell cultures revealed a signiﬁcant
up-regulation of both HNF1a and Cdx2 at both transcript (HNF1a:
7.73 ± 0.74 times relative to ctrl; Cdx2: 3.23 ± 0.28 times relative to
ctrl) and protein levels (Fig. 4A). These results suggest that Src
activity in early differentiation events acts as a negative modulator
of these two regulatory genes associated with the transcription of
both polarity and terminal differentiation markers.
3.4. PP2 treatment reduces PRC2-related activity in intestinal cells
Epigenetic modulation via the polycomb PRC2 complex has re-
cently been shown to be involved in the repression of terminal dif-
ferentiation in intestinal cells [28]. The potential implication of
SFKs on PRC2 activity was therefore tested. As shown in Fig. 4B,
PP2 treatment caused a signiﬁcant decrease in H3K27me3 levels.4. Discussion
A coordinated balance between proliferation and differentiation
is essential for the intestinal epithelium to preserve its constant re-
newal capacity. A key question in intestinal cell biology is what
regulates the initiation of the terminal differentiation process. Re-
cent work from our laboratory has shown that intestine-speciﬁc
transcription factors such as Cdx2 and HNF1a cooperate in the ini-
tiation of the differentiation program while the polycomb PRC2
complex acts as a transient repressor. The SFKs control multiple
cellular events such as adhesion and spreading, migration, apopto-
sis, cell cycle progression and gene transcription [34]. SFKs have
been shown to also be involved in the differentiation of different
cell types such as T cells [12], myoblasts [13], trophoblasts
[17,18], chondrocytes [14] and osteoclasts [10]. However, little is
known regarding the role of SFKs in the regulation of differentia-
tion in human intestinal epithelial cells. In this study we assessed
the effects of the SFK inhibitor PP2 on the initiation of enterocytic
differentiation in human intestinal Caco-2/15 cells and disclosed
that this signaling pathway plays an unsuspected role in the con-
trol of differentiation events. Indeed, we show for the ﬁrst time
that SFK inhibition results in the triggering of intestinal polariza-
tion and terminal differentiation. The effects are quantitatively sig-
niﬁcant as illustrated by SI levels in 3 day PC cells treated with PP2
reaching comparable levels as those found in Caco-2 cells after
20 days at conﬂuence.
In is noteworthy that in addition to SI expression, which is a
major enterocyte terminal differentiation marker [23,25,26], up-
regulated expression of several other terminal differentiation
markers such as LCT and DPP4 as well as cell polarization markers
such as CDH1 and CHD17 [28,30] was observed after PP2 treat-
ment. Although there is evidence that these events are not neces-
sarily coordinated at the cellular level [25,33], they may be
functionally related since Src has been shown to regulate the integ-
Fig. 4. Effect of PP2 on Cdx2 and HNF1a expression and H3K27 trimethylation. Newly conﬂuent cells were treated for 3 days with PP2 or control (DMSO only; Ctrl) in
complete culture medium. (A) Cell lysates were prepared and analysed by immunoblot for detection of HNF1a and Cdx2. Bar graphs show the amounts of both proteins
relative to actin. (n = 3, ⁄⁄⁄p < 0.001 versus Ctrl). (B) Cell lysates were prepared and analysed by immunoblot for detection of the PRC2-associated epigenetic marker
H3K27me3. Bar graph shows the amounts of both proteins relative to actin. (n = 3, ⁄p < 0.05 versus Ctrl).
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a role in the control of cell differentiation [37]. Furthermore, E-cad-
herin-mediated cell–cell contact can trigger p38 MAPK cascade
activation in differentiating enterocytes [38] while Src regulates
p38 MAPK activation [39]. Interestingly, the PI3 K product phos-
phatidylinositol 3,4,5-triphosphate can recruit and activate the
GTP exchange factor for Rac, which is required for adherens junc-
tion formation [40].
In this context the inhibitory effect of PP2 on the polycomb
PRC2 complex is interesting because it has previously been found
that PRC2 mediated histone H3 methylation is active in prolifera-
tive intestinal epithelial cells where it appears to impede intestinal
cell terminal differentiation [28]. Knockdown of the PRC2 compo-
nent Suz12 caused accelerated expression of a subset of differenti-
ation markers including SI and LCT but did not affect polarity
markers. That inhibition of Src was found to increase expression
of all terminal differentiation and polarity markers tested suggests
that SFK activity acts as a negative regulator of enterocytic differ-
entiation on a more general scale, and certainly upstream of
PRC2. A similar role for Src has been identiﬁed in mammary epithe-
lium, where pharmacological inhibition of SFK activity reduced tu-
mor proliferation in a mouse model for breast cancer and was
associated with a signiﬁcant decrease in expression of another
PRC2 component, Ezh2 [41].
A second distinction between Src and PRC2 activity inhibition is
the effect on transcription factor expression. Inhibition of PRC2
activity did not signiﬁcantly affect expression of HNF1a or of
Cdx2 [28] while PP2 triggered up-regulation of both transcription
factors at the mRNA and protein levels. These results are consistent
with a previous study where our group identiﬁed a central role for
these intestinal epithelial cell-speciﬁc transcription factors on ter-
minal differentiation and polarization [30]. Considering the crucial
regulatory role of these factors on the transcription of intestine
speciﬁc genes [30,42,43], the ﬁnding that SFKs tightly regulate
HNF1a and Cdx2 abundance is of signiﬁcant importance.
Taken together, the present work has led to the identiﬁcation of
an original and major effect of SFKs on the enterocytic differentia-
tion program. Based on our observations that SFK inhibition by PP2leads to over-expression of a panel of markers representative of
both epithelial polarization and intestinal terminal differentiation
events, a phenomenon consistent with the up-regulation of the
two main intestinal epithelial cell-speciﬁc transcription factors
Cdx2 and HNF1a and the reduction of polycomb PRC2-related epi-
genetic repressing activity, our data suggest that SFKs are respon-
sible for delayed Caco-2 cell overall differentiation.
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